Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick A. Spencer

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Current Cardiology Reports|July 1, 2005
Heart failure and shock complicating acute coronary syndromesFrederick A Spencer, Theo Meyer
Current Interventional Cardiology Reports|August 4, 2001
Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary InterventionRichard C. Becker, Frederick A. Spencer
Circulation|June 20, 2003
Risk factors for venous thromboembolismFrederick A Anderson, Frederick A Spencer
International Journal of Dermatology|August 24, 2012
Incidence of deep vein thrombosis in erysipelas or cellulitis of the lower extremitiesMohammadreza Mortazavi, Mitra M Samiee, Frederick A Spencer
Journal of Thrombosis and Thrombolysis|January 19, 2016
The epidemiology of venous thromboembolismJohn A Heit, Frederick A Spencer, Richard H White
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 31, 2010
Anatomic distribution of deep vein thrombosis in pregnancyWee-Shian Chan, Frederick A Spencer, Jeffrey S Ginsberg
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|August 9, 2005
A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin eraRobert Mohapatra, Maichi Tran, Joel M Gore, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistanceYouFu Li, Miguel Rodriquez, Frederick A Spencer, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Current Cardiology Reports|July 1, 2005
Heart failure and shock complicating acute coronary syndromesFrederick A Spencer, Theo Meyer
Current Interventional Cardiology Reports|August 4, 2001
Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary InterventionRichard C. Becker, Frederick A. Spencer
Circulation|June 20, 2003
Risk factors for venous thromboembolismFrederick A Anderson, Frederick A Spencer
International Journal of Dermatology|August 24, 2012
Incidence of deep vein thrombosis in erysipelas or cellulitis of the lower extremitiesMohammadreza Mortazavi, Mitra M Samiee, Frederick A Spencer
Journal of Thrombosis and Thrombolysis|January 19, 2016
The epidemiology of venous thromboembolismJohn A Heit, Frederick A Spencer, Richard H White
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 31, 2010
Anatomic distribution of deep vein thrombosis in pregnancyWee-Shian Chan, Frederick A Spencer, Jeffrey S Ginsberg
Journal of Thrombosis and Thrombolysis|October 24, 2003
Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitorYou fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|March 30, 2002
Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibitionYou Fu Li, Frederick A Spencer, Richard C Becker
American Heart Journal|August 9, 2005
A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin eraRobert Mohapatra, Maichi Tran, Joel M Gore, et al.
Journal of Thrombosis and Thrombolysis|April 26, 2003
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistanceYouFu Li, Miguel Rodriquez, Frederick A Spencer, et al.
Pageof 15